Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Karakaya · SciRah

Researcher profile · Semantic Scholar

S. Karakaya

Share profile

S. Karakaya — researcher profile on SciRah

h-index: 12
Works: 80
Citations: 397

Most-cited papers

The neutrophil-lymphocyte ratio and its relationship with insulin resistance in obesity
S. Karakaya, M. Altay, Fatma Kaplan Efe, Ibrahim Karadag +4 more
2019Turkish Journal of Medical Sciences37 citations Open access
Semantic Scholar
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study
E. Yekedüz, D. Tural, İ. Ertürk, S. Karakaya +12 more
2022Journal of Cancer Research and Clinical Oncology32 citations Open access
Semantic Scholar
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer
H. A. Yaşar, Kadriye Bir Yucel, Ç. Arslan, G. Ucar +15 more
2019Journal of Oncology Pharmacy Practice24 citations
Semantic Scholar
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
C. Karaçin, B. Oksuzoglu, A. Demirci, M. Keskinkılıç +82 more
2023BMC Cancer23 citations Open access
Semantic Scholar
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors
K. B. Yücel, E. Yekedüz, S. Karakaya, D. Tural +15 more
2022Scientific Reports19 citations Open access
Semantic Scholar
Can neutrophil/lymphocyte ratio be used as an indicator of inflammation in patients with hyperthyroidism?
M. Dağdeviren, T. Akkan, Dilek Yapar, S. Karakaya +3 more
2019Journal of Medical Biochemistry19 citations Open access
Semantic Scholar
Renal function improves with the treatment of hypothyroidism
O. Bulur, K. Dal, D. Ertuğrul, Murat Eser +7 more
2017Endocrine Research18 citations
Semantic Scholar
The potential prognostic novel markers PIV and PILE score to predict survival outcomes at hepatocellular cancer.
İ. Karadağ, S. Karakaya, M. Yılmaz, Ö. B. Çakmak Öksüzoğlu
2022European Review for Medical and Pharmacological Sciences16 citations
Semantic Scholar
The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels
N. Ata, K. Dal, M. Kucukazman, A. Yeniova +7 more
2014Open Medicine15 citations Open access
Semantic Scholar
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases
S. Kahraman, S. Karakaya, Muhammed Ali Kaplan, S. Goksu +43 more
2024Scientific Reports13 citations Open access
Semantic Scholar
CROSS or FLOT in Distal Esophageal and Gastroesophageal Cancer.
Ibrahim Karadag, S. Karakaya, Öztürk Ateş, Ö. B. Çakmak Öksüzoğlu
2021Journal of the College of Physicians and Surgeons--Pakistan : JCPSP12 citations Open access
Semantic Scholar
Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
M. Hızal, M. A. Şendur, H. A. Yaşar, Kadriye Bir Yucel +14 more
2020Journal of Oncology Pharmacy Practice12 citations
Semantic Scholar
Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders.
A. Yıldırım, A. Koca, E. Beyan, O. Doğan +3 more
2021European Review for Medical and Pharmacological Sciences10 citations
Semantic Scholar
Association of neutrophil-to-lymphocyte ratio and microalbuminuria in patients with normal eGFR
A. A. Kutlugun, F. Ebinç, Mujgan Ozturk, F. Efe +4 more
2018Romanian journal of internal medicine = Revue roumaine de medecine interne10 citations Open access
Semantic Scholar
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.
E. Yekedüz, S. Karakaya, İ. Ertürk, D. Tural +17 more
2022Clinical Genitourinary Cancer8 citations
Semantic Scholar
High Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Low Lymphocyte Levels Are Correlated With Worse Pathological Complete Response Rates
S. Karakaya, Ibrahim Karadag, M. Yılmaz, Ö. B. Çakmak Öksüzoğlu
2022Cureus8 citations Open access
Semantic Scholar
The role of insulin - like growth factor - 1 on steatohepatitis.
K. Dal, O. Bulur, N. Ata, A. Yeniova +7 more
2016Acta gastro-enterologica Belgica8 citations Open access
Semantic Scholar
Prognostic value of hemoglobin-to-red cell distribution width ratio and inflammation markers in colorectal cancer
E. Zeynelgil, Y. Duzkopru, A. Koçanoğlu, S. Karakaya
2025World Journal of Gastrointestinal Oncology7 citations Open access
Semantic Scholar
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database.
E. Yekedüz, İ. Ertürk, D. Tural, N. Karadurmuş +17 more
2021Future Oncology7 citations
Semantic Scholar
Trimester-specific reference intervals of thyroid function tests in Turkish pregnants
O. Bulur, Z. Atak, D. Ertuğrul, E. Beyan +4 more
2019Gynecological Endocrinology7 citations
Semantic Scholar
The Use of Herbal Medicine and Dietary Supplements in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Cross-Sectional Study
Fatih Kuş, Deniz Can Guven, H. Yıldırım, Baran Akagunduz +12 more
2024Integrative Cancer Therapies6 citations Open access
Semantic Scholar
Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous Adenocarcinoma.
T. Demir, Murat Araz, C. Moloney, E. Hendem +9 more
2024Clinical Lung Cancer6 citations
Semantic Scholar
The Potential Prognostic Marker TyG Index Predicts Time to Brain Metastasis at HER2 Positive Breast Cancer
Ibrahim Karadag, S. Karakaya, T. Akkan, B. Demir +2 more
2023Cancer Management and Research6 citations Open access
Semantic Scholar
Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?
G. Ucar, Y. Açikgoz, Y. Ergun, O. Bal +10 more
2020Cureus6 citations Open access
Semantic Scholar
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study
Z. Kalkan, S. Ebinç, M. Arcagok, A. Bilici +10 more
2025Medicina5 citations Open access
Semantic Scholar
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
C. Karaçin, B. Oksuzoglu, A. Demirci, M. Keskinkılıç +82 more
2023BMC Cancer5 citations Open access
Semantic Scholar
Clinical Outcomes and Prognostic Factors in HER-2 Positive Breast Cancer with Brain Metastasis: A Single-centre Experience.
S. Karakaya, Ibrahim Karadag, Öztürk Ateş, Ö. B. Çakmak Öksüzoğlu +1 more
2021Journal of the College of Physicians and Surgeons--Pakistan : JCPSP5 citations Open access
Semantic Scholar
Can neutrophil to lymphocyte ratio or platelet to lymphocyte ratio predict chemotherapy response testicular cancer
S. Karakaya
20215 citations
Semantic Scholar
Do Inflammatory and Nutritional Markers Predict Prognosis in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab
E. Zeynelgil, Dilek Çağlayan, Selahattin Çelik, Hatice Ayyıldız Sevim +3 more
2025Journal of Inflammation Research4 citations Open access
Semantic Scholar
Ideal Lymph Node Number for Ovarian Malignancies
Ibrahim Karadag, S. Karakaya
2022Cureus4 citations Open access
Semantic Scholar
Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data.
Öztürk Ateş, O. Oksuzoglu, B. Aktaş, Ibrahim Karadag +7 more
2021Journal of B.U.ON. : official journal of the Balkan Union of Oncology4 citations
Semantic Scholar
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group.
T. Telli, A. Tatlı, Özkan Alan, Gül Keskin +32 more
2025Clinical Lung Cancer3 citations
Semantic Scholar
Anticipatory Grief and Its Associated Factors in Lung Cancer Patients
R. Tekdemir, Samet Kaya, İhsan Aksoy, S. Karakaya
2024Neuropsychiatric Investigation3 citations Open access
Semantic Scholar
Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group
Mustafa Gürbüz, S. Kılıçkap, A. Bilici, N. Karadurmuş +22 more
2022Medicine3 citations Open access
Semantic Scholar
Clinical outcomes and prognostic factors in HER-2 positive breast cancer with brain metastasis: A single-center experience.
S. Karakaya, Ibrahim Karadag, A. Duran, O. Oksuzoglu +1 more
2020Journal of Clinical Oncology3 citations
Semantic Scholar
Dynamic Alteration of HALP Score as a Predictor in Patients with Receiving Immunotherapy for Advanced Non-Small Cell Lung Cancer
Abdülkadir Koçanoğlu, S. Karakaya, E. Zeynelgil, Yakup Düzköprü +1 more
2025Medicina2 citations Open access
Semantic Scholar
The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis
Nadiye Sever, Sedat Yıldırım, A. Gurbuz, Delyadil Karakaş Kılıç +18 more
2025Medicina2 citations Open access
Semantic Scholar
Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium
C. Erol, E. Yekedüz, D. Tural, S. Karakaya +14 more
2023Urologia internationalis2 citations
Semantic Scholar
Heart rate recovery in patients with inflammatory bowel disease in clinical remission
Oktay Nsal, E. Beyan, Yasemin Nsal, S. Karakaya +4 more
2023Annals of Medical Research2 citations Open access
Semantic Scholar
Lorlatinib-Related Vision Loss: Two Cases of Non-Small Cell Lung Cancer with Blindness
S. Karakaya, Ö. Yıldırım, Şeyma Işık, Ş. Yücel +1 more
2023Journal of Oncological Sciences2 citations Open access
Semantic Scholar
Platelet-to-Lymphocyte Ratio as an Indicator to Predict Decreased Carbon Monoxide Diffusion of the Lung in Patients with Testicular Cancer.
S. Karakaya, Ibrahim Karadag, C. Ozdilekcan, Esra Durmuşoğlu +2 more
2022Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2 citations Open access
Semantic Scholar
Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.
E. Yekeduz, Ismail Erturk, D. Tural, N. Karadurmuş +15 more
20212 citations
Semantic Scholar
Potential Novel Prognostic Factors in Malign Mesothelioma: Systemic Inflammatory Indices (SII) - Albumin-to-Globulin Ratio (AGR)
S. Karakaya, Ibrahim Karadag, M. Doğan, N. Alkış
2021Acta Oncologica Turcica2 citations Open access
Semantic Scholar
Evaluatıon Of Sars-Cov-2 Infectıon In Cancer Patıents: Sıngle-Center Experıence From Turkey
Aysegul Ilhan Güleşen, S. Karakaya, Ibrahim Karadag, Sabahat Çeken +1 more
20202 citations Open access
Semantic Scholar
KRAS Mutation Subtypes, Co-Mutations, PD-L1 Expression, and Survival Outcomes in Non-Small Cell Lung Cancer
N. Gürçay, F. Demirağ, Müzeyyen Burcu Kaplan Yılmaz, İlknur Öz +4 more
2026Journal of Clinical Medicine1 citations Open access
Semantic Scholar
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study.
E. Almuradova, Tuğba Başoğlu, E. Nayır, E. Bayram +27 more
2023Neoplasma (Bratislava)1 citations Open access
Semantic Scholar
Clinicopathological Factors in Relation to HER2 Status in Metastatic Gastric Cancer: A Retrospective Observational Study
Mustafa Gürbüz, I. Dogan, E. Akkuş, Ibrahim Karadag +11 more
2022Journal of Oncological Sciences1 citations Open access
Semantic Scholar
The invisible part of “ICEBERG”:Extraintestinal findings and celiac diseas
S. Karakaya, Ibrahim Karadag, A. Mete, O. Bulur +2 more
2021Turkish journal of clinics and laboratory1 citations Open access
Semantic Scholar
Can systemic inflammatory index (SII) and MELD score predict survival in liver metastatic colorectal cancer?
Ibrahim Karadag, S. Karakaya
2021Turkish journal of clinics and laboratory1 citations Open access
Semantic Scholar
12-Cycle of Temozolomide Treatment is not Superior To 6-Cycle of Treatment in Glioblastoma Multiforme
Ibrahim Karadag, S. Karakaya, Öztürk Ateş, B. Oksuzoglu
20201 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Ibrahim Karadag×21
Invite
Ibrahim Karadag — researcher profile on SciRah
N. Karadurmuş×13
Invite
N. Karadurmuş — researcher profile on SciRah
S. Kılıçkap×12
Invite
S. Kılıçkap — researcher profile on SciRah
M. Şendur×10
Invite
M. Şendur — researcher profile on SciRah

×8

Invite

Ç. Arslan — researcher profile on SciRah

Invite

G. Ucar — researcher profile on SciRah

Invite

İ. Ertürk — researcher profile on SciRah

Invite

C. Erol — researcher profile on SciRah

Invite

Y. Ürün — researcher profile on SciRah

Invite

U. Demirci — researcher profile on SciRah

Invite

I. Çiçin — researcher profile on SciRah

Invite

E. Beyan — researcher profile on SciRah